These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22495532)

  • 1. A seven-day study of the pharmacokinetics of intravenous levetiracetam in neonates: marked changes in pharmacokinetics occur during the first week of life.
    Sharpe CM; Capparelli EV; Mower A; Farrell MJ; Soldin SJ; Haas RH
    Pediatr Res; 2012 Jul; 72(1):43-9. PubMed ID: 22495532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of levetiracetam in neonates with seizures.
    Lima-Rogel V; López-López EJ; Medellín-Garibay SE; Gómez-Ruiz LM; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
    J Clin Pharm Ther; 2018 Jun; 43(3):422-429. PubMed ID: 29265480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of neonatal seizures: focus on Levetiracetam.
    Loiacono G; Masci M; Zaccara G; Verrotti A
    J Matern Fetal Neonatal Med; 2016; 29(1):69-74. PubMed ID: 25385270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam: safety and efficacy in neonatal seizures.
    Ramantani G; Ikonomidou C; Walter B; Rating D; Dinger J
    Eur J Paediatr Neurol; 2011 Jan; 15(1):1-7. PubMed ID: 21094062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intravenous levetiracetam for acute seizure management in preterm neonates.
    Khan O; Cipriani C; Wright C; Crisp E; Kirmani B
    Pediatr Neurol; 2013 Nov; 49(5):340-3. PubMed ID: 23921284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of levetiracetam in neonates with seizures.
    Merhar SL; Schibler KR; Sherwin CM; Meinzen-Derr J; Shi J; Balmakund T; Vinks AA
    J Pediatr; 2011 Jul; 159(1):152-154.e3. PubMed ID: 21592494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
    Patterson EE; Goel V; Cloyd JC; O'Brien TD; Fisher JE; Dunn AW; Leppik IE
    J Vet Pharmacol Ther; 2008 Jun; 31(3):253-8. PubMed ID: 18471147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures.
    Maitre NL; Smolinsky C; Slaughter JC; Stark AR
    J Perinatol; 2013 Nov; 33(11):841-6. PubMed ID: 24051577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Papich MG
    J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Levetiracetam as Add-On Therapy in the Treatment of Seizures in Neonates.
    Rondagh M; De Vries LS; Peeters-Scholte CMPCD; Tromp SC; Steggerda SJ
    Neonatology; 2024; 121(2):233-243. PubMed ID: 38113859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.
    Hardy BT; Patterson EE; Cloyd JM; Hardy RM; Leppik IE
    J Vet Intern Med; 2012; 26(2):334-40. PubMed ID: 22295898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Levetiracetam in Neonates in Clinical Practice: A Retrospective Study at a German University Hospital.
    Neininger MP; Ullmann M; Dahse AJ; Syrbe S; Bernhard MK; Frontini R; Kiess W; Merkenschlager A; Thome U; Bertsche T; Bertsche A
    Neuropediatrics; 2015 Oct; 46(5):329-34. PubMed ID: 26308219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of antiepileptogenic and antiseizure effects of levetiracetam in the spontaneously epileptic rat (SER).
    Yan HD; Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Aug; 46(8):1170-7. PubMed ID: 16060925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic model of levetiracetam in Korean neonates with seizures
.
    Jung YS; Lee SM; Park MS; Park K
    Int J Clin Pharmacol Ther; 2018 May; 56(5):217-223. PubMed ID: 29393846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures.
    Shin JW; Jung YS; Park K; Lee SM; Eun HS; Park MS; Park KI; Namgung R
    Korean J Pediatr; 2017 Feb; 60(2):50-54. PubMed ID: 28289434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.
    Abend NS; Monk HM; Licht DJ; Dlugos DJ
    Pediatr Crit Care Med; 2009 Jul; 10(4):505-10. PubMed ID: 19325512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of levetiracetam in the management of seizures in neonates.
    Sedighi M; Asadi F; Moradian N; Vakiliamini M; Moradian M
    Neurosciences (Riyadh); 2016 Jul; 21(3):232-5. PubMed ID: 27356654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of levetiracetam and its enantiomer (R)-alpha-ethyl-2-oxo-pyrrolidine acetamide in dogs.
    Isoherranen N; Yagen B; Soback S; Roeder M; Schurig V; Bialer M
    Epilepsia; 2001 Jul; 42(7):825-30. PubMed ID: 11488879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of levetiracetam for neonatal seizures in preterm infants.
    Han JY; Moon CJ; Youn YA; Sung IK; Lee IG
    BMC Pediatr; 2018 Apr; 18(1):131. PubMed ID: 29636029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
    Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
    Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.